Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine in Genomic DNA from Hepatocellular Carcinoma Tissues by Capillary Hydrophilic-Interaction Liquid Chromatography/Quadrupole TOF Mass Spectrometry
Author(s) -
Ming-Luan Chen,
Fan Shen,
Wei Huang,
Jiahui Qi,
Yinsheng Wang,
YuQi Feng,
Song-Mei Liu,
BiFeng Yuan
Publication year - 2013
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2012.193938
Subject(s) - 5 hydroxymethylcytosine , hepatocellular carcinoma , epigenetics , chemistry , genomic dna , dna , detection limit , microbiology and biotechnology , liver cancer , tandem mass spectrometry , chromatography , dna methylation , mass spectrometry , biology , cancer research , biochemistry , gene , gene expression
5-Methylcytosine (5-mC) is an important epigenetic modification involved in development and is frequently altered in cancer. 5-mC can be enzymatically converted to 5-hydroxymethylcytosine (5-hmC). 5-hmC modifications are known to be prevalent in DNA of embryonic stem cells and neurons, but the distribution of 5-hmC in human liver tumor and matched control tissues has not been rigorously explored.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom